Consistent with a role as a candidate tumor suppressor gene, "loss of function" alterations in C/EBPδ gene expression have been reported in primary human breast cancer and acute myeloid leukemia (AML) [11,14-18]. This evidence concerns the gene CEBPD and breast carcinoma.